Eroxon Gel: What to Know About the First FDA-Cleared OTC ED Treatment

Eroxon is an over-the-counter topical gel developed for erectile dysfunction. Unlike oral ED medications, it contains no active pharmaceutical ingredient and is regulated as a medical device rather than as a prescription drug.

The FDA De Novo summary identifies Eroxon as a non-medicated topical formulation for treating erectile dysfunction in people who meet the product’s labeled eligibility requirements. The FDA granted the device Class II status through the De Novo pathway in June 2023.

Eroxon provides a different treatment format for people who prefer a topical product available without a prescription. Its clinical findings are encouraging, but they should be interpreted according to the design of the studies, the population evaluated, and the product’s labeled instructions.

Key Takeaways

• Eroxon is an FDA-cleared, non-medicated topical medical device for erectile dysfunction
• The gel produces a localized cooling effect followed by warming, which stimulates nerve endings in the glans penis
• The FDA-reviewed pivotal trial included participants with mild, moderate, and severe ED, although the subgroup findings were exploratory
• The tadalafil group in the pivotal Eroxon study was exploratory and did not establish a formal effectiveness comparison
• Eroxon and oral PDE5 inhibitors use different mechanisms and should be considered as distinct treatment options

What Is Eroxon Gel?

Eroxon, previously known during development as MED3000, is a hydro-alcoholic gel applied directly to the head of the penis immediately before sexual activity.

The FDA classifies it as a non-medicated topical formulation for erectile dysfunction. It does not contain sildenafil, tadalafil, vardenafil, alprostadil, or another active pharmaceutical ingredient.

Each single-use tube contains approximately 0.3 mL of gel. The entire contents are applied to the glans penis and massaged for about 15 seconds.

Eroxon is intended for people who meet the product’s labeled eligibility requirements and experience difficulty achieving or maintaining an erection sufficient for satisfactory sexual activity. Its FDA indication is not limited specifically to mild ED.

What FDA Clearance Means

Eroxon is FDA-cleared through the De Novo classification process. This is different from FDA approval of a pharmaceutical drug.

The De Novo pathway is used for certain medical devices that have no legally marketed predicate device but whose risks can be managed through general and special controls.

The FDA created a new device category for Eroxon:

Non-medicated topical formulation for treatment of erectile dysfunction.

The agency classified Eroxon as a Class II device. Required controls include:

• Biocompatibility testing
• Temperature-profile testing
• Condom-compatibility testing
• Verification of device specifications
• Shelf-life testing
• Clear instructions and safety labeling
• Information that helps users determine whether the product is appropriate for them

FDA clearance confirms that the agency determined the device’s probable benefits outweighed its probable risks for its labeled indication. It does not mean that Eroxon works for every person or that it has been proven superior to prescription ED medication.

How Eroxon Works

According to the FDA De Novo summary, Eroxon creates a rapid localized cooling effect followed by a slower return to warmth.

Alcohol and water in the gel begin evaporating after application. The resulting temperature change stimulates nerve endings in the glans penis, which can contribute to tumescence and erection.

This mechanism differs from the action of PDE5 inhibitors.

Medications such as sildenafil, tadalafil, and vardenafil inhibit the PDE5 enzyme and support the nitric oxide and cyclic GMP pathway involved in penile blood flow. Eroxon instead uses a localized physical effect produced by its formulation.

This difference in mechanism does not establish that either approach is universally more effective. Treatment response depends on the individual, the nature of the erectile symptoms, the product used, and whether it is used according to its instructions.

Sexual stimulation is still required when using Eroxon.

How to Apply Eroxon

The current product instructions describe the following process:

1. Open one single-dose tube
2. Empty the full contents onto the fingers
3. Apply the gel only to the head of the penis
4. Massage the gel into the area for approximately 15 seconds
5. Use the product immediately before sexual activity

A partner may also apply the gel as part of sexual activity.

Each tube contains one dose and is intended for one intercourse attempt. Eroxon is not intended to be used as a general sexual lubricant.

People should read the current package insert before use because instructions, precautions, and compatibility information may be updated.

Safety Findings and Precautions

In the FDA-reviewed pivotal study, one participant using Eroxon experienced mild treatment-related burning at the application site. The discomfort resolved after the participant discontinued use.

The FDA labeling advises users to stop applying the product if burning, itching, redness, or another form of irritation develops. Persistent irritation should receive medical attention.

The product should also be avoided when:

• The user is allergic to an ingredient
• The penile skin is red, sore, damaged, or broken
• A penile disease or deformity is present
• A healthcare provider has advised avoiding sexual activity
• The user does not meet the product’s labeled eligibility requirements

Current labeling should be consulted for condom compatibility and complete precautions.

Eroxon does not act as contraception and does not protect against sexually transmitted infections.

Can Eroxon Be Used With ED Medication?

The use of Eroxon together with PDE5 inhibitors or another ED treatment has not been adequately studied.

Its non-medicated formulation does not automatically establish that every combination is appropriate. The reason for treatment, the user’s medical history, current prescriptions, and previous response may all affect the decision.

Someone considering Eroxon alongside sildenafil, tadalafil, vardenafil, injections, or another ED intervention should discuss the combination with a healthcare provider.

Eroxon Compared With Oral PDE5 Inhibitors

Eroxon and oral PDE5 inhibitors approach erectile function differently.

Eroxon

Eroxon is:

• A non-medicated topical medical device
• Applied directly to the glans penis
• Available without a prescription
• Used immediately before sexual activity
• Designed to create a localized temperature change
• Supplied in single-use tubes

PDE5 Inhibitors

Sildenafil, tadalafil, and vardenafil are:

• Prescription medications
• Taken orally, sublingually, or in another prescribed formulation
• Absorbed into the body
• Used to support the nitric oxide and cyclic GMP pathway
• Selected according to health history, timing preferences, interactions, and treatment response
• Prescribed with healthcare-provider oversight

Current ED management recommendations identify PDE5 inhibitors as first-line pharmacological treatment for most patients while emphasizing individualized treatment decisions.

This recommendation reflects the extensive clinical evidence supporting PDE5 inhibitors and the role of provider assessment in selecting medication. Eroxon remains a separate over-the-counter option with a different mechanism, application method, and evidence base.

Why Direct Comparisons Are Limited

Eroxon and prescription ED medications differ in their mechanisms, administration methods, and clinical evidence. These differences make simple effectiveness comparisons difficult.

The FDA-reviewed Eroxon study included a tadalafil group, but that part of the trial was exploratory. It was not designed to establish that Eroxon or tadalafil was consistently more effective than the other.

Treatment choice may depend on factors such as:

• How frequently erectile symptoms occur
• Previous treatment response
• Medical history
• Current medications
• Preference for topical or prescription treatment
• Desired timing and duration
• Comfort with provider involvement
• Whether further evaluation is appropriate

Eroxon may appeal to someone who prefers an over-the-counter topical product applied immediately before sexual activity. Prescription treatment may suit someone seeking provider guidance, access to different active ingredients, or another timing and duration profile.

The appropriate option depends on the person’s symptoms, health history, preferences, and previous treatment experience.

Where Eroxon Fits Among OTC Products

Before Eroxon, nonprescription products marketed for erectile performance commonly included supplements, unapproved topical products, and mechanical devices.

Eroxon differs because it received FDA clearance specifically for treating erectile dysfunction.

It is currently sold without a prescription through participating U.S. retailers and online channels. Retail availability, package sizes, and prices may change, so current listings should be checked directly.

FDA clearance should not be confused with a guarantee of results. Users should still follow the label, monitor their response, and seek care when symptoms persist or change.

When Erectile Symptoms Deserve Evaluation

OTC access can make treatment more convenient, but it does not identify why ED is occurring.

ED can involve vascular, neurological, hormonal, medication-related, psychological, and relationship factors. More than one contributor may be present.

A healthcare provider may review:

• How long the symptoms have been present
• Whether they occur consistently or intermittently
• Current prescriptions and supplements
• Cardiovascular and blood-pressure history
• Diabetes or other metabolic conditions
• Sexual desire and arousal
• Previous treatment response
• Psychological or relationship factors
• Whether examination or testing is appropriate

New, persistent, painful, or worsening erectile symptoms should not be managed solely by repeatedly changing OTC products.

Where BlueChew Fits Into the Discussion

BlueChew uses a different access model from Eroxon.

Eroxon is purchased over the counter and used according to its product label. BlueChew is a telemedicine service that connects patients with licensed healthcare providers who may prescribe compounded ED medication when medically appropriate.

Someone seeking treatment through BlueChew completes a digital medical intake. A provider reviews the submitted health information, medications, and treatment history before determining whether a prescription is appropriate.

This provider-reviewed process may be useful for someone who:

• Wants to discuss prescription ED medication
• Has questions about treatment selection
• Has experienced an incomplete response to another option
• Takes medications that may affect treatment choice
• Wants access to different active ingredients or formulations
• Prefers a telemedicine consultation to an in-person appointment

BlueChew should not be presented as prescribing Eroxon or as offering the same type of treatment. Its products are compounded prescription medications, while Eroxon is a non-medicated OTC device.

BlueChew Product Options

BlueChew’s complete product lineup includes:

• SIL: 45 mg sildenafil, from $2.95/tablet, works in 15 minutes, lasting up to 6 hours
• TAD: 9 mg tadalafil, from $3.58/tablet, effective within 15 minutes, lasting up to 36 hours
• VAR: 8 mg vardenafil, from $4.34/tablet, takes effect in 15 minutes, lasting up to 6 hours
• DailyTAD: 9 mg tadalafil plus 7 essential vitamins, $2.23/tablet, lasting up to 36 hours
• MAX: 45 mg sildenafil + 18 mg tadalafil combo, $5.63/tablet, lasting up to 36 hours
• VMAX: 14 mg vardenafil + 18 mg tadalafil combo, $5.63/tablet, lasting up to 36 hours
• GOLD: sildenafil, tadalafil, oxytocin, and apomorphine sublingual tablet, from $7.30/tablet, lasting up to 36 hours

Product strengths, pricing, availability, and plan terms may change. The licensed healthcare provider determines whether a prescription and particular formulation are appropriate.

How To Get Medication Through BlueChew

Interested in getting your hands on a prescription for BlueChew GOLD? BlueChew has got you covered.

Select a plan, complete an online intake, and you’re done. A medical provider will review your information and, if appropriate, prescribe your plan, which will be shipped directly to your door.

No doctor appointments or patient support charges make it a stress-free experience.

Plus, there’s no commitment—you can easily cancel or switch plans anytime. Click here to explore all plan options for treatments at BlueChew.

Frequently Asked Questions

Is Eroxon FDA-approved?

Eroxon is FDA-cleared rather than FDA-approved as a drug. The FDA granted it De Novo classification as a Class II, non-medicated topical medical device. It is indicated for treating erectile dysfunction in people who meet the product’s labeled eligibility requirements. This regulatory status is different from the approval process used for prescription medications.

How quickly can Eroxon work?

In the pivotal study, approximately 63% of participants reported noticing an erection within 10 minutes of application. Just over half reported being able to have penetrative sex within 15 minutes. These results describe findings from the study and do not guarantee a specific onset for every user. Eroxon is applied immediately before sexual activity, and sexual stimulation is required.

Is Eroxon intended only for mild ED?

Eroxon’s FDA indication is not restricted to mild ED. The pivotal study included participants with mild, moderate, and severe erectile dysfunction. However, the subgroup findings were exploratory and involved relatively small numbers of participants. Individual response may vary regardless of severity classification.

Can Eroxon be used with sildenafil or tadalafil?

Combined use with PDE5 inhibitors has not been adequately studied. Eroxon’s non-medicated formulation does not mean every combination is automatically suitable. A healthcare provider can review current medications, health conditions, and previous treatment response before different ED products are used together. Users should also follow the current Eroxon label.

How should someone choose between Eroxon and prescription treatment?

Eroxon offers OTC access, topical application, and use immediately before sexual activity. Prescription treatments offer provider oversight and access to established pharmacological options with different timing and duration profiles. The appropriate approach depends on symptoms, health history, current medications, preferences, and previous response. Persistent or changing ED may deserve clinical evaluation even when an OTC product is available.

This article is provided for informational purposes only and does not constitute medical advice. The information presented is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider to discuss the risks, benefits, and appropriateness of any treatment.

BlueChew offers access to healthcare providers who may prescribe compounded medications for the treatment of erectile dysfunction.

The featured products include compounded medications that have not been approved by the FDA. Compounded medications may be prescribed under federal law but are not the same as, nor are they generic versions of, any FDA-approved medication. The FDA does not review compounded medications for safety, effectiveness, or manufacturing quality of compounded products. A prescription will only be written if deemed appropriate after the digital consultation by the licensed medical provider. Individual results may vary.

BlueChew is not a compounding pharmacy but a telemedicine service that links patients to licensed medical providers.